LifeTech Scientific Corporation
LFTSF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $7,266 | $7,464 | $7,584 | $6,848 |
| - Cash | $783 | $666 | $833 | $979 |
| + Debt | $4 | $5 | $104 | $9 |
| Enterprise Value | $6,487 | $6,803 | $6,856 | $5,878 |
| Revenue | $677 | $651 | $653 | $628 |
| % Growth | 4% | -0.3% | 4% | – |
| Gross Profit | $498 | $466 | $515 | $491 |
| % Margin | 73.6% | 71.6% | 78.9% | 78.2% |
| EBITDA | $71 | $80 | $208 | $122 |
| % Margin | 10.5% | 12.4% | 31.9% | 19.4% |
| Net Income | $55 | $17 | $206 | $43 |
| % Margin | 8.1% | 2.6% | 31.5% | 6.9% |
| EPS Diluted | 0.013 | 0.004 | 0.046 | 0.01 |
| % Growth | 225.6% | -91.6% | 371.4% | – |
| Operating Cash Flow | $391 | $219 | $103 | $195 |
| Capital Expenditures | -$22 | -$102 | -$181 | -$101 |
| Free Cash Flow | $370 | $117 | -$78 | $94 |